Published in Blood on January 15, 1997
Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A (2008) 2.21
Nonnatural protein-protein interaction-pair design by key residues grafting. Proc Natl Acad Sci U S A (2007) 1.30
Erythropoietin. Cold Spring Harb Perspect Med (2013) 1.28
Wiggle-predicting functionally flexible regions from primary sequence. PLoS Comput Biol (2006) 1.03
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol Med (2010) 1.02
Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment. Proc Natl Acad Sci U S A (2004) 1.00
Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex. Mol Cell (2009) 1.00
Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. J Virol (1998) 0.97
Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells. Br J Cancer (2008) 0.96
Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward? J Investig Med (2011) 0.92
Delayed administration of pyroglutamate helix B surface peptide (pHBSP), a novel nonerythropoietic analog of erythropoietin, attenuates acute kidney injury. Mol Med (2012) 0.91
Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration. Hum Mol Genet (2011) 0.89
Mutant erythropoietin without erythropoietic activity is neuroprotective against ischemic brain injury. Stroke (2012) 0.88
Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity. Exp Hematol (2006) 0.84
Discovery and basic pharmacology of erythropoiesis-stimulating agents (ESAs), including the hyperglycosylated ESA, darbepoetin alfa: an update of the rationale and clinical impact. Eur J Clin Pharmacol (2010) 0.84
Potential of Novel EPO Derivatives in Limb Ischemia. Cardiol Res Pract (2012) 0.81
Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis. Expert Opin Ther Targets (2015) 0.81
Cysteine promoted C-terminal hydrazinolysis of native peptides and proteins. Angew Chem Int Ed Engl (2013) 0.79
Structural identification of modified amino acids on the interface between EPO and its receptor from EPO BRP, human recombinant erythropoietin by LC/MS analysis. Mol Cells (2014) 0.79
Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation. Cell (2017) 0.78
Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG-PLA micelle. Int J Nanomedicine (2012) 0.78
Targeted erythropoietin selectively stimulates red blood cell expansion in vivo. Proc Natl Acad Sci U S A (2016) 0.78
The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin. PLoS One (2015) 0.77
A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin. PLoS One (2012) 0.75
Topological transformation of liposomes by a membrane-affecting domain of recombinant human erythropoietin. J Liposome Res (2010) 0.75
Cellular level models as tools for cytokine design. Biotechnol Prog (2010) 0.75
Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol (2000) 5.81
T-cell co-stimulation through B7RP-1 and ICOS. Nature (1999) 4.20
Lactic acidosis rates in type 2 diabetes. Diabetes Care (1998) 3.40
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci U S A (2000) 3.37
Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem (1981) 3.21
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol (1999) 3.21
Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03
Notch activity influences the alphabeta versus gammadelta T cell lineage decision. Cell (1997) 2.66
Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc Natl Acad Sci U S A (1977) 2.45
An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell (1996) 2.42
Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest (1994) 2.14
Induction of midbrain dopaminergic neurons by Sonic hedgehog. Neuron (1995) 2.08
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99
Spontaneous pneumothorax and mitral valve prolapse. Chest (1986) 1.99
Reconciliation of international administrative coding systems for comparison of colorectal surgery outcome. Colorectal Dis (2014) 1.91
ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J Biol Chem (1994) 1.88
Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2. J Biol Chem (1996) 1.87
Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology (2000) 1.78
Effects of cisapride on QT interval in children. J Pediatr (1998) 1.59
Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry (1989) 1.55
Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem (1994) 1.51
Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem (1990) 1.51
Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med (1989) 1.51
Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J Lab Clin Med (1995) 1.49
Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol (1996) 1.49
Acute enlargement and subsequent rupture of an abdominal aortic aneurysm in a patient receiving chemotherapy for pancreatic carcinoma. J Vasc Surg (2000) 1.48
Indirect detection of intraoperative carbon monoxide exposure by mass spectrometry during isoflurane anesthesia. Anesthesiology (1995) 1.44
Maternal recall of infant feeding events is accurate. J Epidemiol Community Health (1992) 1.42
Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes (1990) 1.41
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience. Control Clin Trials (2001) 1.39
Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly. J Biol Chem (1994) 1.32
Amino acid sequence of rabbit muscle aldolase and the structure of the active center. Science (1974) 1.32
Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun (2001) 1.30
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24
Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg (1998) 1.24
p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells. J Virol (1992) 1.24
Primary structure of cholera toxin subunit A1: isolation, partial sequences and alignment of the BrCN fragments. FEBS Lett (1979) 1.20
Cloning and characterization of B delta, a novel regulatory subunit of protein phosphatase 2A. FEBS Lett (1999) 1.20
A novel chordin-like protein inhibitor for bone morphogenetic proteins expressed preferentially in mesenchymal cell lineages. Dev Biol (2001) 1.19
Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs (1996) 1.19
Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg (1999) 1.17
Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry (1992) 1.16
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg (1995) 1.15
Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors. Transfusion (2004) 1.15
Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. Am J Physiol Lung Cell Mol Physiol (2000) 1.15
Role of p53 in cell cycle regulation and apoptosis following exposure to proteasome inhibitors. Cell Growth Differ (2000) 1.14
The effects of intra-arterial vasoconstrictors on the distribution of a radiolabelled low molecular weight marker in an experimental model of liver tumour. Br J Cancer (1991) 1.14
Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties. J Biol Chem (1996) 1.14
Hydrazinonaphthalene and azonaphthalene thrombopoietin mimics are nonpeptidyl promoters of megakaryocytopoiesis. J Med Chem (2001) 1.13
Pleuropulmonary melioidosis in a Cambodian refugee. Can Med Assoc J (1984) 1.12
Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer (1996) 1.12
CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins. Biochemistry (1988) 1.11
Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg (1996) 1.11
Inhibition of gastric and intestinal motor activity in dogs by (Gln4) neurotensin. Acta Physiol Scand (1977) 1.10
Women's health and social change: the case of lay midwives. Int J Health Serv (1988) 1.10
Human surfactant protein D: SP-D contains a C-type lectin carbohydrate recognition domain. Arch Biochem Biophys (1991) 1.09
Effect of donor ethnicity on kidney survival in different recipient pairs: an analysis of the OPTN/UNOS database. Transplant Proc (2009) 1.09
Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor. Proc Natl Acad Sci U S A (1990) 1.08
Pancreastatin and islet hormone release. Proc Natl Acad Sci U S A (1987) 1.08
Early recognition of atypical Francisella tularensis strains lacking a cysteine requirement. J Clin Microbiol (1994) 1.07
Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology (1998) 1.06
Risk of early-onset proliferative retinopathy in IDDM is closely related to cardiovascular autonomic neuropathy. Diabetes (1992) 1.06
Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood (1988) 1.06
Metabolic engineering as therapy for inborn errors of metabolism--development of mice with phenylalanine hydroxylase expression in muscle. Gene Ther (1998) 1.05
Thrombolytic therapy: what is its role in free flap salvage? Ann Plast Surg (2001) 1.05
Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera. J Immunol (2000) 1.05
Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg (2000) 1.04
Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation. FEBS Lett (2001) 1.04
Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer (2004) 1.04
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer (1999) 1.04
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis. Eur J Surg Oncol (2011) 1.04
An analysis of errors in kinematic parameters associated with in vivo functional radiographs. Spine (Phila Pa 1976) (1992) 1.03
Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc Natl Acad Sci U S A (1994) 1.02
Localization of hepatitis delta virus RNA in the nucleus of human cells. RNA (1998) 1.02
Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol (1998) 1.02
The major capsid protein, VP1, of human JC virus expressed in Escherichia coli is able to self-assemble into a capsid-like particle and deliver exogenous DNA into human kidney cells. J Gen Virol (1999) 1.01
Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis. Am J Pathol (1991) 1.01
Anastomotic leak after double-stapled low colorectal resection. Dis Colon Rectum (1996) 1.00
Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors. Blood (1997) 1.00
Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology (1981) 0.99
Depressor and natriuretic activities of several atrial peptides. Regul Pept (1984) 0.98
Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J Pathol (1993) 0.98
Developmental expression of pulmonary surfactant protein D (SP-D). Am J Respir Cell Mol Biol (1991) 0.98
Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes. Am J Respir Cell Mol Biol (1995) 0.98
Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons. Science (1983) 0.97
Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion. J Biol Chem (1996) 0.97
IgG monoclonal gammopathy in four patients with polymyalgia rheumatica. Ann Rheum Dis (1985) 0.96
Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis (1998) 0.96
Carbohydrate modifications of the high mobility group proteins. Proc Natl Acad Sci U S A (1981) 0.96
Mutations in the putative calcium-binding domain of polyomavirus VP1 affect capsid assembly. J Virol (1993) 0.95
ARIA is concentrated in nerve terminals at neuromuscular junctions and at other synapses. J Neurosci (1995) 0.95
The diagnosis and early complications of right ventricular infarction. Eur J Nucl Med (1984) 0.94
Efficacy of a proximal occlusion catheter with reversal of flow in the prevention of embolic events during carotid artery stenting: an experimental analysis. J Vasc Surg (2001) 0.94
Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Similarities and differences of the alpha and beta isoforms. J Biol Chem (1995) 0.94
Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system. J Virol (1997) 0.94
Spontaneous hematoma of a parathyroid adenoma. Am J Med Sci (1989) 0.94
Inhibition of gastric acid secretion in dogs by neurotensin. Life Sci (1976) 0.94
HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro. J Leukoc Biol (1997) 0.94